Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Suvorexant for Cocaine Use Disorder
NCT03937986Phase 1Completed
- Start
- Jul 2019
- Primary completion
- Apr 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of suvorexant in cocaine use disorder (CUD) (4 arms). Primary endpoint: Reinforcing Effects of Cocaine at 1 month. Started Jul 2019; status: completed.
02
Drugs
suvorexant
03
Conditions
cocaine use disorder (CUD)
Beyond the preview
Go deeper on NCT03937986.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03937986.